{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
USAN:HIOXIFILCON B [USAN]
Source URL:
Class:
POLYMER
Status:
Investigational
Class:
POLYMER
Status:
Investigational
Source:
USAN:SAFROFILCON A [USAN]
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
USAN:PHEMFILCON A [USAN]
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
INN:bofelisimer [INN]
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
USAN:SENOFILCON A [USAN]
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
USAN:HIOXIFILCON A [USAN]
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
INN:pegmispotide [INN]
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
NCT03435640: Phase 1/Phase 2 Interventional Terminated Melanoma
(2018)
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
NCT04571645: Phase 3 Interventional Terminated Acute Myeloid Leukemia
(2021)
Source URL:
Class:
POLYMER